Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.

NCT03697226 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

HSIL of Cervix
HSIL, High Grade Squamous Intraepithelial Lesions
High-Grade Cervical Intraepithelial Neoplasia
Human Papilloma Virus
HIV Negative
Cervical Cancer
CIN - Cervical Intraepithelial Neoplasia
Cervical Neoplasm
Cervical Dysplasia

Interventions

DRUG: Topical ABI-1968

Sponsor

Antiva Biosciences